The effect of calf muscular vein thrombosis on elderly Chinese patients with hip fracture

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069411

Enrollment

Unknown

Registered

2023-03-15

Start date

2023-03-16

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Hip fracture combined without calf muscular vein thrombosis group:None

Hip fracture combined with calf muscular vein thrombosis group:None

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Acute hip fractures including femoral neck and intertrochanteric fractures; 2. Fractures proven by X-ray or CT preoperatively; 3. Treatment with internal fixation such as hollow nails, DHS, FNS and PFNA or arthroplasty.

Exclusion criteria

Exclusion criteria: 1. Aged < 65 years; 2. Multiple fractures; 3. Pathological fractures; 4. Open fractures; 5. Previous history of hip replacement or venous embolism; 6. Fracture with neurovascular injury; 7. Incomplete clinical data; 8. Combined deep vein thrombosis at other sites than calf muscular vein thrombosis.

Design outcomes

Primary

Measure	Time frame
Mortality within one year after operation;	—

Secondary

Measure	Time frame
Postoperative complications;Progression rate of venous thrombosis;Total postoperative hospitalization days;Survival time;Long-term function after operation;	—

Countries

China

Contacts

Public ContactZhou Xiang

West China Hospital, Sichuan University

xiangzhouI5@hotmail.com+86 18980601393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026